chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bordetella test negative, COVID-19, COVID-19 pneumonia, Cardiac arrest, Chest X-ray abnormal
Clinical narrative: Narrative:  70-year-old male patient with past medical history most significant for hypertension, hyperlipidemia, diabetes, sleep apnea, anemia, CLL (treated with Ibrutinib), thrombocytopenia, and recent diagnosis of COVID-19 who presented to the Emergency Department complaining of generalized weakness and shortness of breath. Patient was walking from the bathroom back to his chair when he felt so weak that he could not make it all way to his chair. He denied any injuries, head or neck pain, back pain, hip or pelvis pain, extremity pain. EMS was called. He stated he had been short of breath. EMS checked room air saturation several times and stated it was roughly 55%. He was placed on nonrebreather with oxygen saturations in the 70s, then additional 6 L via nasal cannula was added at which point he was satting 88 to 94%. Patient stated that he was feeling well once he was on oxygen. In the ED he was receiving 15 L via nonrebreather satting 89%, placed on HFNC @ 40L & 60% FiO2. He had persistent general malaise/weakness but no focal symptoms. He denied chest pain, palpitations, lightheadedness. He had had no recent fever or chills. He stated he has had recent diffuse mild dull myalgias after his flu shot on 9/23/2021. Otherwise afebrile, BP 144/113, HR 115, RR 20. Labs significant for leukocytosis to 15.5 with left shift, Hgb 9.3, procal 1.57, lactic acid 1.75, d-dimer >20. U/A with 20 ketones. He was admitted on 10/10/2021. On 10/17, the patient had an acute decompensation. He had been weaned to nasal cannula (6L) but had a rapidly increasing oxygen requirement. Subsequent ABG 7.47/34/39, patient in severe respiratory distress. He was intubated and was hypoxic in the 70s despite 100% FIO2. Inhaled NO was started with improvement in hypoxemia. CTPE negative for PE. Source of presume sepsis is due to a superimposed bacterial pneumonia and wide spectrum antibiotics were prescribed. The goal was to wean the patient eventually from the ventilator but on 10/21/2021, the patient had PEA arrest and passed away.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chlamydia test negative, Computerised tomogram thorax normal, Coronavirus test negative, Death, Dyspnoea
Clinical narrative: Narrative:  70-year-old male patient with past medical history most significant for hypertension, hyperlipidemia, diabetes, sleep apnea, anemia, CLL (treated with Ibrutinib), thrombocytopenia, and recent diagnosis of COVID-19 who presented to the Emergency Department complaining of generalized weakness and shortness of breath. Patient was walking from the bathroom back to his chair when he felt so weak that he could not make it all way to his chair. He denied any injuries, head or neck pain, back pain, hip or pelvis pain, extremity pain. EMS was called. He stated he had been short of breath. EMS checked room air saturation several times and stated it was roughly 55%. He was placed on nonrebreather with oxygen saturations in the 70s, then additional 6 L via nasal cannula was added at which point he was satting 88 to 94%. Patient stated that he was feeling well once he was on oxygen. In the ED he was receiving 15 L via nonrebreather satting 89%, placed on HFNC @ 40L & 60% FiO2. He had persistent general malaise/weakness but no focal symptoms. He denied chest pain, palpitations, lightheadedness. He had had no recent fever or chills. He stated he has had recent diffuse mild dull myalgias after his flu shot on 9/23/2021. Otherwise afebrile, BP 144/113, HR 115, RR 20. Labs significant for leukocytosis to 15.5 with left shift, Hgb 9.3, procal 1.57, lactic acid 1.75, d-dimer >20. U/A with 20 ketones. He was admitted on 10/10/2021. On 10/17, the patient had an acute decompensation. He had been weaned to nasal cannula (6L) but had a rapidly increasing oxygen requirement. Subsequent ABG 7.47/34/39, patient in severe respiratory distress. He was intubated and was hypoxic in the 70s despite 100% FIO2. Inhaled NO was started with improvement in hypoxemia. CTPE negative for PE. Source of presume sepsis is due to a superimposed bacterial pneumonia and wide spectrum antibiotics were prescribed. The goal was to wean the patient eventually from the ventilator but on 10/21/2021, the patient had PEA arrest and passed away.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Enterovirus test negative, Fibrin D dimer, Fraction of inspired oxygen, Gait disturbance
Clinical narrative: Narrative:  70-year-old male patient with past medical history most significant for hypertension, hyperlipidemia, diabetes, sleep apnea, anemia, CLL (treated with Ibrutinib), thrombocytopenia, and recent diagnosis of COVID-19 who presented to the Emergency Department complaining of generalized weakness and shortness of breath. Patient was walking from the bathroom back to his chair when he felt so weak that he could not make it all way to his chair. He denied any injuries, head or neck pain, back pain, hip or pelvis pain, extremity pain. EMS was called. He stated he had been short of breath. EMS checked room air saturation several times and stated it was roughly 55%. He was placed on nonrebreather with oxygen saturations in the 70s, then additional 6 L via nasal cannula was added at which point he was satting 88 to 94%. Patient stated that he was feeling well once he was on oxygen. In the ED he was receiving 15 L via nonrebreather satting 89%, placed on HFNC @ 40L & 60% FiO2. He had persistent general malaise/weakness but no focal symptoms. He denied chest pain, palpitations, lightheadedness. He had had no recent fever or chills. He stated he has had recent diffuse mild dull myalgias after his flu shot on 9/23/2021. Otherwise afebrile, BP 144/113, HR 115, RR 20. Labs significant for leukocytosis to 15.5 with left shift, Hgb 9.3, procal 1.57, lactic acid 1.75, d-dimer >20. U/A with 20 ketones. He was admitted on 10/10/2021. On 10/17, the patient had an acute decompensation. He had been weaned to nasal cannula (6L) but had a rapidly increasing oxygen requirement. Subsequent ABG 7.47/34/39, patient in severe respiratory distress. He was intubated and was hypoxic in the 70s despite 100% FIO2. Inhaled NO was started with improvement in hypoxemia. CTPE negative for PE. Source of presume sepsis is due to a superimposed bacterial pneumonia and wide spectrum antibiotics were prescribed. The goal was to wean the patient eventually from the ventilator but on 10/21/2021, the patient had PEA arrest and passed away.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haemoglobin decreased, Hilar lymphadenopathy, Human metapneumovirus test, Human rhinovirus test, Hypoxia
Clinical narrative: Narrative:  70-year-old male patient with past medical history most significant for hypertension, hyperlipidemia, diabetes, sleep apnea, anemia, CLL (treated with Ibrutinib), thrombocytopenia, and recent diagnosis of COVID-19 who presented to the Emergency Department complaining of generalized weakness and shortness of breath. Patient was walking from the bathroom back to his chair when he felt so weak that he could not make it all way to his chair. He denied any injuries, head or neck pain, back pain, hip or pelvis pain, extremity pain. EMS was called. He stated he had been short of breath. EMS checked room air saturation several times and stated it was roughly 55%. He was placed on nonrebreather with oxygen saturations in the 70s, then additional 6 L via nasal cannula was added at which point he was satting 88 to 94%. Patient stated that he was feeling well once he was on oxygen. In the ED he was receiving 15 L via nonrebreather satting 89%, placed on HFNC @ 40L & 60% FiO2. He had persistent general malaise/weakness but no focal symptoms. He denied chest pain, palpitations, lightheadedness. He had had no recent fever or chills. He stated he has had recent diffuse mild dull myalgias after his flu shot on 9/23/2021. Otherwise afebrile, BP 144/113, HR 115, RR 20. Labs significant for leukocytosis to 15.5 with left shift, Hgb 9.3, procal 1.57, lactic acid 1.75, d-dimer >20. U/A with 20 ketones. He was admitted on 10/10/2021. On 10/17, the patient had an acute decompensation. He had been weaned to nasal cannula (6L) but had a rapidly increasing oxygen requirement. Subsequent ABG 7.47/34/39, patient in severe respiratory distress. He was intubated and was hypoxic in the 70s despite 100% FIO2. Inhaled NO was started with improvement in hypoxemia. CTPE negative for PE. Source of presume sepsis is due to a superimposed bacterial pneumonia and wide spectrum antibiotics were prescribed. The goal was to wean the patient eventually from the ventilator but on 10/21/2021, the patient had PEA arrest and passed away.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Imaging procedure artifact, Influenza A virus test negative, Influenza B virus test, Leukocytosis, Lung consolidation
Clinical narrative: Narrative:  70-year-old male patient with past medical history most significant for hypertension, hyperlipidemia, diabetes, sleep apnea, anemia, CLL (treated with Ibrutinib), thrombocytopenia, and recent diagnosis of COVID-19 who presented to the Emergency Department complaining of generalized weakness and shortness of breath. Patient was walking from the bathroom back to his chair when he felt so weak that he could not make it all way to his chair. He denied any injuries, head or neck pain, back pain, hip or pelvis pain, extremity pain. EMS was called. He stated he had been short of breath. EMS checked room air saturation several times and stated it was roughly 55%. He was placed on nonrebreather with oxygen saturations in the 70s, then additional 6 L via nasal cannula was added at which point he was satting 88 to 94%. Patient stated that he was feeling well once he was on oxygen. In the ED he was receiving 15 L via nonrebreather satting 89%, placed on HFNC @ 40L & 60% FiO2. He had persistent general malaise/weakness but no focal symptoms. He denied chest pain, palpitations, lightheadedness. He had had no recent fever or chills. He stated he has had recent diffuse mild dull myalgias after his flu shot on 9/23/2021. Otherwise afebrile, BP 144/113, HR 115, RR 20. Labs significant for leukocytosis to 15.5 with left shift, Hgb 9.3, procal 1.57, lactic acid 1.75, d-dimer >20. U/A with 20 ketones. He was admitted on 10/10/2021. On 10/17, the patient had an acute decompensation. He had been weaned to nasal cannula (6L) but had a rapidly increasing oxygen requirement. Subsequent ABG 7.47/34/39, patient in severe respiratory distress. He was intubated and was hypoxic in the 70s despite 100% FIO2. Inhaled NO was started with improvement in hypoxemia. CTPE negative for PE. Source of presume sepsis is due to a superimposed bacterial pneumonia and wide spectrum antibiotics were prescribed. The goal was to wean the patient eventually from the ventilator but on 10/21/2021, the patient had PEA arrest and passed away.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lung disorder, Lung opacity, Lymphadenopathy mediastinal, Malaise, Mechanical ventilation
Clinical narrative: Narrative:  70-year-old male patient with past medical history most significant for hypertension, hyperlipidemia, diabetes, sleep apnea, anemia, CLL (treated with Ibrutinib), thrombocytopenia, and recent diagnosis of COVID-19 who presented to the Emergency Department complaining of generalized weakness and shortness of breath. Patient was walking from the bathroom back to his chair when he felt so weak that he could not make it all way to his chair. He denied any injuries, head or neck pain, back pain, hip or pelvis pain, extremity pain. EMS was called. He stated he had been short of breath. EMS checked room air saturation several times and stated it was roughly 55%. He was placed on nonrebreather with oxygen saturations in the 70s, then additional 6 L via nasal cannula was added at which point he was satting 88 to 94%. Patient stated that he was feeling well once he was on oxygen. In the ED he was receiving 15 L via nonrebreather satting 89%, placed on HFNC @ 40L & 60% FiO2. He had persistent general malaise/weakness but no focal symptoms. He denied chest pain, palpitations, lightheadedness. He had had no recent fever or chills. He stated he has had recent diffuse mild dull myalgias after his flu shot on 9/23/2021. Otherwise afebrile, BP 144/113, HR 115, RR 20. Labs significant for leukocytosis to 15.5 with left shift, Hgb 9.3, procal 1.57, lactic acid 1.75, d-dimer >20. U/A with 20 ketones. He was admitted on 10/10/2021. On 10/17, the patient had an acute decompensation. He had been weaned to nasal cannula (6L) but had a rapidly increasing oxygen requirement. Subsequent ABG 7.47/34/39, patient in severe respiratory distress. He was intubated and was hypoxic in the 70s despite 100% FIO2. Inhaled NO was started with improvement in hypoxemia. CTPE negative for PE. Source of presume sepsis is due to a superimposed bacterial pneumonia and wide spectrum antibiotics were prescribed. The goal was to wean the patient eventually from the ventilator but on 10/21/2021, the patient had PEA arrest and passed away.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia, Mycoplasma test negative, Pneumonia bacterial, Procalcitonin, Pulseless electrical activity
Clinical narrative: Narrative:  70-year-old male patient with past medical history most significant for hypertension, hyperlipidemia, diabetes, sleep apnea, anemia, CLL (treated with Ibrutinib), thrombocytopenia, and recent diagnosis of COVID-19 who presented to the Emergency Department complaining of generalized weakness and shortness of breath. Patient was walking from the bathroom back to his chair when he felt so weak that he could not make it all way to his chair. He denied any injuries, head or neck pain, back pain, hip or pelvis pain, extremity pain. EMS was called. He stated he had been short of breath. EMS checked room air saturation several times and stated it was roughly 55%. He was placed on nonrebreather with oxygen saturations in the 70s, then additional 6 L via nasal cannula was added at which point he was satting 88 to 94%. Patient stated that he was feeling well once he was on oxygen. In the ED he was receiving 15 L via nonrebreather satting 89%, placed on HFNC @ 40L & 60% FiO2. He had persistent general malaise/weakness but no focal symptoms. He denied chest pain, palpitations, lightheadedness. He had had no recent fever or chills. He stated he has had recent diffuse mild dull myalgias after his flu shot on 9/23/2021. Otherwise afebrile, BP 144/113, HR 115, RR 20. Labs significant for leukocytosis to 15.5 with left shift, Hgb 9.3, procal 1.57, lactic acid 1.75, d-dimer >20. U/A with 20 ketones. He was admitted on 10/10/2021. On 10/17, the patient had an acute decompensation. He had been weaned to nasal cannula (6L) but had a rapidly increasing oxygen requirement. Subsequent ABG 7.47/34/39, patient in severe respiratory distress. He was intubated and was hypoxic in the 70s despite 100% FIO2. Inhaled NO was started with improvement in hypoxemia. CTPE negative for PE. Source of presume sepsis is due to a superimposed bacterial pneumonia and wide spectrum antibiotics were prescribed. The goal was to wean the patient eventually from the ventilator but on 10/21/2021, the patient had PEA arrest and passed away.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Respiratory distress, Respiratory syncytial virus test negative, Respirovirus test, Rubulavirus test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  70-year-old male patient with past medical history most significant for hypertension, hyperlipidemia, diabetes, sleep apnea, anemia, CLL (treated with Ibrutinib), thrombocytopenia, and recent diagnosis of COVID-19 who presented to the Emergency Department complaining of generalized weakness and shortness of breath. Patient was walking from the bathroom back to his chair when he felt so weak that he could not make it all way to his chair. He denied any injuries, head or neck pain, back pain, hip or pelvis pain, extremity pain. EMS was called. He stated he had been short of breath. EMS checked room air saturation several times and stated it was roughly 55%. He was placed on nonrebreather with oxygen saturations in the 70s, then additional 6 L via nasal cannula was added at which point he was satting 88 to 94%. Patient stated that he was feeling well once he was on oxygen. In the ED he was receiving 15 L via nonrebreather satting 89%, placed on HFNC @ 40L & 60% FiO2. He had persistent general malaise/weakness but no focal symptoms. He denied chest pain, palpitations, lightheadedness. He had had no recent fever or chills. He stated he has had recent diffuse mild dull myalgias after his flu shot on 9/23/2021. Otherwise afebrile, BP 144/113, HR 115, RR 20. Labs significant for leukocytosis to 15.5 with left shift, Hgb 9.3, procal 1.57, lactic acid 1.75, d-dimer >20. U/A with 20 ketones. He was admitted on 10/10/2021. On 10/17, the patient had an acute decompensation. He had been weaned to nasal cannula (6L) but had a rapidly increasing oxygen requirement. Subsequent ABG 7.47/34/39, patient in severe respiratory distress. He was intubated and was hypoxic in the 70s despite 100% FIO2. Inhaled NO was started with improvement in hypoxemia. CTPE negative for PE. Source of presume sepsis is due to a superimposed bacterial pneumonia and wide spectrum antibiotics were prescribed. The goal was to wean the patient eventually from the ventilator but on 10/21/2021, the patient had PEA arrest and passed away.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Scan with contrast abnormal, Sepsis, Shift to the left, Superinfection, Urine analysis abnormal
Clinical narrative: Narrative:  70-year-old male patient with past medical history most significant for hypertension, hyperlipidemia, diabetes, sleep apnea, anemia, CLL (treated with Ibrutinib), thrombocytopenia, and recent diagnosis of COVID-19 who presented to the Emergency Department complaining of generalized weakness and shortness of breath. Patient was walking from the bathroom back to his chair when he felt so weak that he could not make it all way to his chair. He denied any injuries, head or neck pain, back pain, hip or pelvis pain, extremity pain. EMS was called. He stated he had been short of breath. EMS checked room air saturation several times and stated it was roughly 55%. He was placed on nonrebreather with oxygen saturations in the 70s, then additional 6 L via nasal cannula was added at which point he was satting 88 to 94%. Patient stated that he was feeling well once he was on oxygen. In the ED he was receiving 15 L via nonrebreather satting 89%, placed on HFNC @ 40L & 60% FiO2. He had persistent general malaise/weakness but no focal symptoms. He denied chest pain, palpitations, lightheadedness. He had had no recent fever or chills. He stated he has had recent diffuse mild dull myalgias after his flu shot on 9/23/2021. Otherwise afebrile, BP 144/113, HR 115, RR 20. Labs significant for leukocytosis to 15.5 with left shift, Hgb 9.3, procal 1.57, lactic acid 1.75, d-dimer >20. U/A with 20 ketones. He was admitted on 10/10/2021. On 10/17, the patient had an acute decompensation. He had been weaned to nasal cannula (6L) but had a rapidly increasing oxygen requirement. Subsequent ABG 7.47/34/39, patient in severe respiratory distress. He was intubated and was hypoxic in the 70s despite 100% FIO2. Inhaled NO was started with improvement in hypoxemia. CTPE negative for PE. Source of presume sepsis is due to a superimposed bacterial pneumonia and wide spectrum antibiotics were prescribed. The goal was to wean the patient eventually from the ventilator but on 10/21/2021, the patient had PEA arrest and passed away.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urine ketone body present, White blood cell count increased
Clinical narrative: Narrative:  70-year-old male patient with past medical history most significant for hypertension, hyperlipidemia, diabetes, sleep apnea, anemia, CLL (treated with Ibrutinib), thrombocytopenia, and recent diagnosis of COVID-19 who presented to the Emergency Department complaining of generalized weakness and shortness of breath. Patient was walking from the bathroom back to his chair when he felt so weak that he could not make it all way to his chair. He denied any injuries, head or neck pain, back pain, hip or pelvis pain, extremity pain. EMS was called. He stated he had been short of breath. EMS checked room air saturation several times and stated it was roughly 55%. He was placed on nonrebreather with oxygen saturations in the 70s, then additional 6 L via nasal cannula was added at which point he was satting 88 to 94%. Patient stated that he was feeling well once he was on oxygen. In the ED he was receiving 15 L via nonrebreather satting 89%, placed on HFNC @ 40L & 60% FiO2. He had persistent general malaise/weakness but no focal symptoms. He denied chest pain, palpitations, lightheadedness. He had had no recent fever or chills. He stated he has had recent diffuse mild dull myalgias after his flu shot on 9/23/2021. Otherwise afebrile, BP 144/113, HR 115, RR 20. Labs significant for leukocytosis to 15.5 with left shift, Hgb 9.3, procal 1.57, lactic acid 1.75, d-dimer >20. U/A with 20 ketones. He was admitted on 10/10/2021. On 10/17, the patient had an acute decompensation. He had been weaned to nasal cannula (6L) but had a rapidly increasing oxygen requirement. Subsequent ABG 7.47/34/39, patient in severe respiratory distress. He was intubated and was hypoxic in the 70s despite 100% FIO2. Inhaled NO was started with improvement in hypoxemia. CTPE negative for PE. Source of presume sepsis is due to a superimposed bacterial pneumonia and wide spectrum antibiotics were prescribed. The goal was to wean the patient eventually from the ventilator but on 10/21/2021, the patient had PEA arrest and passed away.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  91yo patient died on 9/27/21. Last note in records from PCC on 7/1/2021 stating "Patient is a 80yo MALE here to reestablish care. he was in a near fatal MVA last year and suffered lumbar vertebral fx which resulted in nerve damage. he has neuropathy and bowel/bladder incontinence. he was placed in a NH after the accident... CURRENT PROBLEM LIST: Cerebral aneurysm, nonruptured (ICD-9-CMAllergies (ICD-9-CM 995.3) Hyperlipidemia (SCT 55822004) Acquired sensorineural hearing loss (SCT 609125008) Erectile dysfunction (SCT 397803000) Ulcerative Colitis (ICD-9-CM 556.9) Hiatal hernia (ICD-9-CM 553.3) Arthritis, Rheumatoid (ICD-9-CM 714.0) Subjective tinnitus (ICD-9-CM 388.31) Carcinoma of prostate (SCT 254900004) Past Medical History: 1) allergies 2) hearing loss 3) UC 4) RA 5) prostate ca - initially had seed implants, then cryo, last bx was neg about 6 months ago 6) ED 7) HLP 8) cerebral aneurysm 9) a fib - nov 2015 10) cochlear implant in jan 2019" No further info since then regarding circumstances of pt's death. Pt did receive covid vaccines on 4/9/21 & 5/11/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Bipolar disorder, Cognitive disorder, Death, Eating disorder, Failure to thrive
Clinical narrative: Narrative:  72yo patient residing at nursing facility died on 9/21/21 at LTC facility. Daughter reported that after speaking to facility ANRP today about Hospice care, she received a 2nd call from ANRP informing her that her father had died in his sleep at facility. Pt was diagnosed with (PTSD), Unspecified bipolar and Mild neurocognitive disorder & failure to thrive as he had stopped eating. Pt had received a covid vaccine (J&J) on 5/5/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and length of time between date of vaccines and date of death.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Post-traumatic stress disorder
Clinical narrative: Narrative:  72yo patient residing at nursing facility died on 9/21/21 at LTC facility. Daughter reported that after speaking to facility ANRP today about Hospice care, she received a 2nd call from ANRP informing her that her father had died in his sleep at facility. Pt was diagnosed with (PTSD), Unspecified bipolar and Mild neurocognitive disorder & failure to thrive as he had stopped eating. Pt had received a covid vaccine (J&J) on 5/5/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and length of time between date of vaccines and date of death.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  94yo patient was discharged from outside agency hospital to rehab on 9/21/21. On 9/30/21 pt died. No info given on circumstances of pt's death. PROBLEM LAST MOD PROVIDER Low vision left eye, normal vision right eye 10/04/2021 (SCT 334311000119108) (ICD-10-CM H54.52A1) Essential hypertension (SCT 59621000) (ICD-10-CM 12/09/2019 I10.) Orthostatic hypotension (SCT 28651003) 12/09/2019 (ICD-10-CM I95.1) Parkinson's disease (SCT 49049000) (ICD-10-CM 12/09/2019 G20.) Age related macular degeneration (SCT 267718000) 08/08/2019 (ICD-10-CM H35.30) Transient cerebral ischemia (SCT 266257000) 12/18/2018 (ICD-10-CM G45.9) Dementia due to Alzheimer's disease (SCT 06/20/2017 142811000119104) (ICD-10-CM G30.9) Allergic rhinitis (SCT 61582004) (ICD-10-CM 03/29/2017 J30.9) Coronary arteriosclerosis (SCT 53741008) 03/29/2017 (ICD-10-CM I25.10) Sick sinus syndrome (SCT 36083008) (ICD-10-CM 03/29/2017 I49.5) Cardiac pacemaker in situ (SCT 441509002) 03/29/2017 (ICD-10-CM Z95.0) Diabetes mellitus (SCT 73211009) (ICD-10-CM 03/04/2016 E11.9) Diabetic neuropathy (SCT 230572002) (ICD-10-CM 03/29/2017 E11.40) Atrial fibrillation (SCT 49436004) (ICD-10-CM 05/07/2020 I48.21) Tinnitus (SCT 60862001) (ICD-9-CM 388.30) 07/14/2014 Pseudophakia (SCT 95217000) (ICD-9-CM 379.39) 07/14/2014 Sleep apnea (SCT 73430006) (ICD-10-CM G47.33) 03/29/2017 History of calculus of kidney (SCT 429025008) 07/14/2014 (ICD-9-CM V13.01) Other Disorders of Iron Metabolism (SCT 03/29/2017 Pt had received covid vaccines on 1/16/21 & 2/23/21. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Chest pain, Cough, Haemoptysis, Immunoglobulin therapy
Clinical narrative: Patient received Janssen COVID vaccine on 3/26/21, then was diagnosed with cardiomyopathy on June 2021. On 10/11/21, patient was found to be COVID positive at another facility.  On 10/22/21, patient came to our facility with hemoptysis and was found to have small clot in the right upper lobe and in the right lower lobe with ground glass opacities from CT. In the ED, patient went to asystole and received 2 rounds of CPR along with epinephrine and bicarb briefly achieved ROSC followed by a second asystolic arrest requiring another round of bicarb, epinephrine and 2 rounds of CPR.  Repeat CT did not show PE. Patient was started on hypothermia protocol and transferred to CCU. Patient was an shock presumably cardiogenic shock and initially started on pressors and patient required 3 pressors including epinephrine, norepinephrine and dobutamine but patient developed tachycardia and went into A. fib with RVR and dobutamine was discontinued.  Repeat echocardiogram showed systolic heart failure EF of 10 to 15% with dilated atrium and ventricle.  Patient went into acute renal failure and was anuric requiring CVVH.  Patient also developed ischemic hepatitis.  Continue to have hemoptysis with critically elevated PTT and anticoagulation has been transitioned to argatroban (from heparin) and later was held because of ongoing hemoptysis.  Patient completed rewarming on 10/25/21 and remained unresponsive and in shock probably secondary to hypoxemic ischemic encephalopathy and neurology has been consulted. Patient expired on 10/26/21.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Thrombocytopenia, Thrombosis, Vaccination complication
Clinical narrative: Patient received Janssen COVID vaccine on 3/26/21, then was diagnosed with cardiomyopathy on June 2021. On 10/11/21, patient was found to be COVID positive at another facility.  On 10/22/21, patient came to our facility with hemoptysis and was found to have small clot in the right upper lobe and in the right lower lobe with ground glass opacities from CT. In the ED, patient went to asystole and received 2 rounds of CPR along with epinephrine and bicarb briefly achieved ROSC followed by a second asystolic arrest requiring another round of bicarb, epinephrine and 2 rounds of CPR.  Repeat CT did not show PE. Patient was started on hypothermia protocol and transferred to CCU. Patient was an shock presumably cardiogenic shock and initially started on pressors and patient required 3 pressors including epinephrine, norepinephrine and dobutamine but patient developed tachycardia and went into A. fib with RVR and dobutamine was discontinued.  Repeat echocardiogram showed systolic heart failure EF of 10 to 15% with dilated atrium and ventricle.  Patient went into acute renal failure and was anuric requiring CVVH.  Patient also developed ischemic hepatitis.  Continue to have hemoptysis with critically elevated PTT and anticoagulation has been transitioned to argatroban (from heparin) and later was held because of ongoing hemoptysis.  Patient completed rewarming on 10/25/21 and remained unresponsive and in shock probably secondary to hypoxemic ischemic encephalopathy and neurology has been consulted. Patient expired on 10/26/21.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time prolonged, Acute kidney injury, Anticoagulant therapy, Atrial fibrillation, COVID-19
Clinical narrative: Patient received Janssen COVID vaccine on 3/26/21, then was diagnosed with cardiomyopathy on June 2021. On 10/11/21, patient was found to be COVID positive at another facility.  On 10/22/21, patient came to our facility with hemoptysis and was found to have small clot in the right upper lobe and in the right lower lobe with ground glass opacities from CT. In the ED, patient went to asystole and received 2 rounds of CPR along with epinephrine and bicarb briefly achieved ROSC followed by a second asystolic arrest requiring another round of bicarb, epinephrine and 2 rounds of CPR.  Repeat CT did not show PE. Patient was started on hypothermia protocol and transferred to CCU. Patient was an shock presumably cardiogenic shock and initially started on pressors and patient required 3 pressors including epinephrine, norepinephrine and dobutamine but patient developed tachycardia and went into A. fib with RVR and dobutamine was discontinued.  Repeat echocardiogram showed systolic heart failure EF of 10 to 15% with dilated atrium and ventricle.  Patient went into acute renal failure and was anuric requiring CVVH.  Patient also developed ischemic hepatitis.  Continue to have hemoptysis with critically elevated PTT and anticoagulation has been transitioned to argatroban (from heparin) and later was held because of ongoing hemoptysis.  Patient completed rewarming on 10/25/21 and remained unresponsive and in shock probably secondary to hypoxemic ischemic encephalopathy and neurology has been consulted. Patient expired on 10/26/21.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Cardiogenic shock, Cardiomyopathy, Computerised tomogram thorax abnormal, Continuous haemodiafiltration
Clinical narrative: Patient received Janssen COVID vaccine on 3/26/21, then was diagnosed with cardiomyopathy on June 2021. On 10/11/21, patient was found to be COVID positive at another facility.  On 10/22/21, patient came to our facility with hemoptysis and was found to have small clot in the right upper lobe and in the right lower lobe with ground glass opacities from CT. In the ED, patient went to asystole and received 2 rounds of CPR along with epinephrine and bicarb briefly achieved ROSC followed by a second asystolic arrest requiring another round of bicarb, epinephrine and 2 rounds of CPR.  Repeat CT did not show PE. Patient was started on hypothermia protocol and transferred to CCU. Patient was an shock presumably cardiogenic shock and initially started on pressors and patient required 3 pressors including epinephrine, norepinephrine and dobutamine but patient developed tachycardia and went into A. fib with RVR and dobutamine was discontinued.  Repeat echocardiogram showed systolic heart failure EF of 10 to 15% with dilated atrium and ventricle.  Patient went into acute renal failure and was anuric requiring CVVH.  Patient also developed ischemic hepatitis.  Continue to have hemoptysis with critically elevated PTT and anticoagulation has been transitioned to argatroban (from heparin) and later was held because of ongoing hemoptysis.  Patient completed rewarming on 10/25/21 and remained unresponsive and in shock probably secondary to hypoxemic ischemic encephalopathy and neurology has been consulted. Patient expired on 10/26/21.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Dilatation atrial, Dilatation ventricular, Echocardiogram abnormal, Ejection fraction decreased
Clinical narrative: Patient received Janssen COVID vaccine on 3/26/21, then was diagnosed with cardiomyopathy on June 2021. On 10/11/21, patient was found to be COVID positive at another facility.  On 10/22/21, patient came to our facility with hemoptysis and was found to have small clot in the right upper lobe and in the right lower lobe with ground glass opacities from CT. In the ED, patient went to asystole and received 2 rounds of CPR along with epinephrine and bicarb briefly achieved ROSC followed by a second asystolic arrest requiring another round of bicarb, epinephrine and 2 rounds of CPR.  Repeat CT did not show PE. Patient was started on hypothermia protocol and transferred to CCU. Patient was an shock presumably cardiogenic shock and initially started on pressors and patient required 3 pressors including epinephrine, norepinephrine and dobutamine but patient developed tachycardia and went into A. fib with RVR and dobutamine was discontinued.  Repeat echocardiogram showed systolic heart failure EF of 10 to 15% with dilated atrium and ventricle.  Patient went into acute renal failure and was anuric requiring CVVH.  Patient also developed ischemic hepatitis.  Continue to have hemoptysis with critically elevated PTT and anticoagulation has been transitioned to argatroban (from heparin) and later was held because of ongoing hemoptysis.  Patient completed rewarming on 10/25/21 and remained unresponsive and in shock probably secondary to hypoxemic ischemic encephalopathy and neurology has been consulted. Patient expired on 10/26/21.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haemoptysis, Hypoxic-ischaemic encephalopathy, Intensive care, Ischaemic hepatitis, Left ventricular failure
Clinical narrative: Patient received Janssen COVID vaccine on 3/26/21, then was diagnosed with cardiomyopathy on June 2021. On 10/11/21, patient was found to be COVID positive at another facility.  On 10/22/21, patient came to our facility with hemoptysis and was found to have small clot in the right upper lobe and in the right lower lobe with ground glass opacities from CT. In the ED, patient went to asystole and received 2 rounds of CPR along with epinephrine and bicarb briefly achieved ROSC followed by a second asystolic arrest requiring another round of bicarb, epinephrine and 2 rounds of CPR.  Repeat CT did not show PE. Patient was started on hypothermia protocol and transferred to CCU. Patient was an shock presumably cardiogenic shock and initially started on pressors and patient required 3 pressors including epinephrine, norepinephrine and dobutamine but patient developed tachycardia and went into A. fib with RVR and dobutamine was discontinued.  Repeat echocardiogram showed systolic heart failure EF of 10 to 15% with dilated atrium and ventricle.  Patient went into acute renal failure and was anuric requiring CVVH.  Patient also developed ischemic hepatitis.  Continue to have hemoptysis with critically elevated PTT and anticoagulation has been transitioned to argatroban (from heparin) and later was held because of ongoing hemoptysis.  Patient completed rewarming on 10/25/21 and remained unresponsive and in shock probably secondary to hypoxemic ischemic encephalopathy and neurology has been consulted. Patient expired on 10/26/21.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lung opacity, Pulmonary thrombosis, Renal failure, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: Patient received Janssen COVID vaccine on 3/26/21, then was diagnosed with cardiomyopathy on June 2021. On 10/11/21, patient was found to be COVID positive at another facility.  On 10/22/21, patient came to our facility with hemoptysis and was found to have small clot in the right upper lobe and in the right lower lobe with ground glass opacities from CT. In the ED, patient went to asystole and received 2 rounds of CPR along with epinephrine and bicarb briefly achieved ROSC followed by a second asystolic arrest requiring another round of bicarb, epinephrine and 2 rounds of CPR.  Repeat CT did not show PE. Patient was started on hypothermia protocol and transferred to CCU. Patient was an shock presumably cardiogenic shock and initially started on pressors and patient required 3 pressors including epinephrine, norepinephrine and dobutamine but patient developed tachycardia and went into A. fib with RVR and dobutamine was discontinued.  Repeat echocardiogram showed systolic heart failure EF of 10 to 15% with dilated atrium and ventricle.  Patient went into acute renal failure and was anuric requiring CVVH.  Patient also developed ischemic hepatitis.  Continue to have hemoptysis with critically elevated PTT and anticoagulation has been transitioned to argatroban (from heparin) and later was held because of ongoing hemoptysis.  Patient completed rewarming on 10/25/21 and remained unresponsive and in shock probably secondary to hypoxemic ischemic encephalopathy and neurology has been consulted. Patient expired on 10/26/21.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Shock, Tachycardia, Unresponsive to stimuli
Clinical narrative: Patient received Janssen COVID vaccine on 3/26/21, then was diagnosed with cardiomyopathy on June 2021. On 10/11/21, patient was found to be COVID positive at another facility.  On 10/22/21, patient came to our facility with hemoptysis and was found to have small clot in the right upper lobe and in the right lower lobe with ground glass opacities from CT. In the ED, patient went to asystole and received 2 rounds of CPR along with epinephrine and bicarb briefly achieved ROSC followed by a second asystolic arrest requiring another round of bicarb, epinephrine and 2 rounds of CPR.  Repeat CT did not show PE. Patient was started on hypothermia protocol and transferred to CCU. Patient was an shock presumably cardiogenic shock and initially started on pressors and patient required 3 pressors including epinephrine, norepinephrine and dobutamine but patient developed tachycardia and went into A. fib with RVR and dobutamine was discontinued.  Repeat echocardiogram showed systolic heart failure EF of 10 to 15% with dilated atrium and ventricle.  Patient went into acute renal failure and was anuric requiring CVVH.  Patient also developed ischemic hepatitis.  Continue to have hemoptysis with critically elevated PTT and anticoagulation has been transitioned to argatroban (from heparin) and later was held because of ongoing hemoptysis.  Patient completed rewarming on 10/25/21 and remained unresponsive and in shock probably secondary to hypoxemic ischemic encephalopathy and neurology has been consulted. Patient expired on 10/26/21.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Aspiration joint, Aspiration joint normal, Borrelia test negative, C-reactive protein normal
Clinical narrative: new onset monoarticular arthritis (right knee) on 6/27/21 (18 days after 2nd Pfizer COVID dose); self limited and now appears to have resolved, suggestive of reactive flare vs. new onset rheumatologic disease.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chlamydia test negative, Full blood count normal, Gram stain negative, HLA-B*27 positive, Joint effusion
Clinical narrative: new onset monoarticular arthritis (right knee) on 6/27/21 (18 days after 2nd Pfizer COVID dose); self limited and now appears to have resolved, suggestive of reactive flare vs. new onset rheumatologic disease.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Joint swelling, Sexually transmitted disease test, Weight bearing difficulty
Clinical narrative: new onset monoarticular arthritis (right knee) on 6/27/21 (18 days after 2nd Pfizer COVID dose); self limited and now appears to have resolved, suggestive of reactive flare vs. new onset rheumatologic disease.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthritis, Laboratory test, Magnetic resonance imaging, X-ray
Clinical narrative: new onset monoarticular arthritis (right knee) on 6/27/21 (18 days after 2nd Pfizer COVID dose); self limited and now appears to have resolved, suggestive of reactive flare vs. new onset rheumatologic disease.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blindness, Dizziness, Investigation, Optic nerve injury, Photopsia
Clinical narrative: Blindness in Right Eye after Pfizer Covid-19 mRNA Vaccine. Covid-19 infection 1/23/20 Antibody Test 2/10/21 Pfizer Covid-19 mRNA Vaccine 2/24/21 Pfizer Covid-19 mRNA Vaccine 3/15/21 Dizzyness 5/1/21 Bright Lights when eyes closed Botox shot Left Scalenus 6/3/21 Eye Dr. referral to Ophthalmology 7/2/21 - Denied Blind in Right Eye 7/22/21 No family history of blindness, all wore glasses NAION diagnosis due to lack of other explanation Occurred after Covid-19 infection and 2 Pfizer mRNA Vaccine shot Botox shot in Left Scalenus No other unusual events
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 antibody test, Thrombosis
Clinical narrative: Blindness in Right Eye after Pfizer Covid-19 mRNA Vaccine. Covid-19 infection 1/23/20 Antibody Test 2/10/21 Pfizer Covid-19 mRNA Vaccine 2/24/21 Pfizer Covid-19 mRNA Vaccine 3/15/21 Dizzyness 5/1/21 Bright Lights when eyes closed Botox shot Left Scalenus 6/3/21 Eye Dr. referral to Ophthalmology 7/2/21 - Denied Blind in Right Eye 7/22/21 No family history of blindness, all wore glasses NAION diagnosis due to lack of other explanation Occurred after Covid-19 infection and 2 Pfizer mRNA Vaccine shot Botox shot in Left Scalenus No other unusual events
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blindness unilateral, Dizziness, Inappropriate schedule of product administration, Polymerase chain reaction, SARS-CoV-1 test
Clinical narrative: Blindness in Right Eye after Pfizer Covid-19 mRNA Vaccine. Covid-19 infection 1/23/20 Antibody Test 2/10/21 Pfizer Covid-19 mRNA Vaccine 2/24/21 Pfizer Covid-19 mRNA Vaccine 3/15/21 Dizzyness 5/1/21 Bright Lights when eyes closed Botox shot Left Scalenus 6/3/21 Eye Dr. referral to Ophthalmology 7/2/21 - Denied Blind in Right Eye 7/22/21 No family history of blindness, all wore glasses NAION diagnosis due to lack of other explanation Occurred after Covid-19 infection and 2 Pfizer mRNA Vaccine shot Botox shot in Left Scalenus No other unusual events
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Antibody test, Blindness unilateral, Botulinum toxin injection, COVID-19, Computerised tomogram
Clinical narrative: Blindness in Right Eye after Pfizer Covid-19 mRNA Vaccine. Covid-19 infection 1/23/20 Antibody Test 2/10/21 Pfizer Covid-19 mRNA Vaccine 2/24/21 Pfizer Covid-19 mRNA Vaccine 3/15/21 Dizzyness 5/1/21 Bright Lights when eyes closed Botox shot Left Scalenus 6/3/21 Eye Dr. referral to Ophthalmology 7/2/21 - Denied Blind in Right Eye 7/22/21 No family history of blindness, all wore glasses NAION diagnosis due to lack of other explanation Occurred after Covid-19 infection and 2 Pfizer mRNA Vaccine shot Botox shot in Left Scalenus No other unusual events
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Magnetic resonance imaging, Optic ischaemic neuropathy, Photopsia
Clinical narrative: Blindness in Right Eye after Pfizer Covid-19 mRNA Vaccine. Covid-19 infection 1/23/20 Antibody Test 2/10/21 Pfizer Covid-19 mRNA Vaccine 2/24/21 Pfizer Covid-19 mRNA Vaccine 3/15/21 Dizzyness 5/1/21 Bright Lights when eyes closed Botox shot Left Scalenus 6/3/21 Eye Dr. referral to Ophthalmology 7/2/21 - Denied Blind in Right Eye 7/22/21 No family history of blindness, all wore glasses NAION diagnosis due to lack of other explanation Occurred after Covid-19 infection and 2 Pfizer mRNA Vaccine shot Botox shot in Left Scalenus No other unusual events
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient received her two Moderna doses too close together due to scheduling and documentation confusion.  Received dose #1 Moderna on 7/27/21. Received dose #2 Moderna on 8/18/21.  (3 weeks and 1 day apart)
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received her two Moderna doses too close together due to scheduling and documentation confusion.  Received dose #1 Moderna on 7/27/21. Received dose #2 Moderna on 8/18/21.  (3 weeks and 1 day apart)
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles on my neck 7 to 8 days after vaccination.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: SOB unresponsive
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, SARS-CoV-2 test, Unresponsive to stimuli
Clinical narrative: SOB unresponsive
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood test, Chest X-ray, Computerised tomogram head, Dizziness, Fibrin D dimer
Clinical narrative: Follow up: Symptoms got extra more severe - even worse: the nausea and the dizziness - it was getting very bad. Nausea making it hard to eat. I lost a lot of weight. I weigh 95 lbs now - I think I was at 110 before. I called 9-1-1. The nausea was caused by the more severe symptoms of dizziness. I can feel like a beating in my ear. It happens in both but not at the same time - sometimes the right one and sometimes the left ear. I  have it every day but not all the time. I had an appt today with my regular doctor. Had been given Steroid - Prednisone - last week for five days and it didn't work. The doctor says I need to see a specialist. No new treatment. I am seeing  a cardiologist and have been referred ENT doctor and neurologist doctor. I get an episode of dizziness and nausea  and it goes away and  then I get it back - every day it comes back. When it happens it may go away for a couple of hours or so, but the next day I either wake up with it or I get it later (the severe dizziness). Once I get it, it usually last the whole day - I just don't know what time I'm going to get it. I've had three CT scans in the past and can't do anymore right this time.